87 related articles for article (PubMed ID: 3255319)
1. Molecular requirements for antimuscarinic activity in 1,3-oxathiolanes.
Angeli P; Bacchiocchi D; Giannella M; Pigini M; Romanelli MN
Drug Des Deliv; 1988 May; 2(4):263-72. PubMed ID: 3255319
[TBL] [Abstract][Full Text] [Related]
2. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane 3-oxide methiodides.
Romanelli MN; Gualtieri F; Angeli P; Picchio MT
J Med Chem; 1989 Oct; 32(10):2269-73. PubMed ID: 2795598
[TBL] [Abstract][Full Text] [Related]
3. Novel 'soft' anticholinergic agents.
Hammer RH; Amin K; Gunes ZE; Brouillette G; Bodor N
Drug Des Deliv; 1988 Feb; 2(3):207-19. PubMed ID: 3255315
[TBL] [Abstract][Full Text] [Related]
4. Correlation analysis in a set of X-benzyltrimethylammonium derivatives with antimuscarinic activity.
De Amici M; De Micheli C; Pratesi P; Grana E; Santagostino Barbone MG; Cappello B; Silipo C; Vittoria A
Farmaco Sci; 1987 Jun; 42(6):409-24. PubMed ID: 3653389
[TBL] [Abstract][Full Text] [Related]
5. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
[TBL] [Abstract][Full Text] [Related]
6. 5-HT2C antagonists based on fused heterotricyclic templates: design, synthesis and biological evaluation.
Hamprecht D; Micheli F; Tedesco G; Donati D; Petrone M; Terreni S; Wood M
Bioorg Med Chem Lett; 2007 Jan; 17(2):424-7. PubMed ID: 17079142
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of the criticality of chiral centers toward stereoselective recognition: epimeric eudismic analysis of 1,3-oxathiolane muscarinic agonists and antagonists.
Lehmann PA
Chirality; 1990; 2(4):211-8. PubMed ID: 2083143
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
9. 1,3-oxathiolane muscarinic ligands modified at the cationic head.
Teodori E; Dei S; Romanelli MN; Scappecchi S; Gualtieri F; Angeli P; Marucci G; Matucci R
Farmaco; 1994 May; 49(5):305-12. PubMed ID: 8080612
[TBL] [Abstract][Full Text] [Related]
10. [Muscarinic activity of cis and trans isomers of 5-membered cyclic compounds].
Grana E
Farmaco Sci; 1984 Jan; 39(1):23-5. PubMed ID: 6705910
[TBL] [Abstract][Full Text] [Related]
11. Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variations.
Chackalamannil S; Doller D; McQuade R; Ruperto V
Bioorg Med Chem Lett; 2004 Aug; 14(15):3967-70. PubMed ID: 15225708
[TBL] [Abstract][Full Text] [Related]
12. Bicyclic dioxolanes as potential antimuscarinic agents.
Piergentili A; Angeli P; Giannella M; Pigini M; Quaglia W; Tayebati SK
Arzneimittelforschung; 1996 Feb; 46(2):99-105. PubMed ID: 8720297
[TBL] [Abstract][Full Text] [Related]
13. Research on heterocyclic compounds. XXXVIII. Synthesis and pharmacological activity of imidazo[1,2-b]pyridazine-2-carboxylic derivatives.
Luraschi E; Arena F; Sacchi A; Laneri S; Abignente E; Avallone L; D'Amico M; Berrino L; Rossi F
Farmaco; 1997 Apr; 52(4):213-7. PubMed ID: 9241825
[TBL] [Abstract][Full Text] [Related]
14. Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides.
Romanelli MN; Teodori E; Gualtieri F; Angeli P; Brasili L
J Med Chem; 1988 Sep; 31(9):1698-702. PubMed ID: 3411598
[TBL] [Abstract][Full Text] [Related]
15. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
16. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides.
Romanelli MN; Gualtieri F; Valle G; Brasili L; Angeli P
J Med Chem; 1988 Sep; 31(9):1703-8. PubMed ID: 3411599
[TBL] [Abstract][Full Text] [Related]
17. [Structure-activity relationship in the series of muscarinic acetylcholine receptor agonists: three types of agonist-receptor complexes].
Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS
Bioorg Khim; 1985 Oct; 11(10):1391-401. PubMed ID: 4074399
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship in a new series of atropine analogs. II. The effect of an asymmetric N-substituent on the antimuscarinic activity.
Cherkez S; Yellin H; Kashman Y; Yaavetz B; Sokolovsky M
Mol Pharmacol; 1978 Sep; 14(5):781-6. PubMed ID: 714023
[No Abstract] [Full Text] [Related]
19. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
20. [Structure-activity relationship in the series of muscarinic acetylcholine receptor antagonists: four types of antagonist-receptor binding].
Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS
Bioorg Khim; 1985 Oct; 11(10):1402-16. PubMed ID: 4074400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
